Japanese pharma major Takeda has agreed a multi-year collaboration with the Indonesian government to build the country’s ...

The biotech infrastructure sector has changed significantly since the biotechnology funding peak of 2021. Less venture ...

Chai Discovery has signed a collaboration with Novartis (NOVN: VX) to use artificial intelligence in the discovery of ...

UK clinical-stage biotech Elevara Medicines today announced the appointment of Mai-Britt Zocca as chief executive (CEO), ...

AstraZeneca (LSE: AZN) has entered into an exclusive license agreement with Shanghai-based Dizal Pharmaceutical (SSE: 688192) for Zegfrovy (sunvozertinib), a novel oral irreversible epidermal growth ...

39-43 Putney High Street, Putney London, SW15 1SP United Kingdom ...

Borealis Bio emerged from stealth in August 2024 with $150 million in combined Series A financing from founding investor Versant Ventures and Novartis AG, as well as committed strategic research ...

A clinical-stage biopharmaceutical company pioneering immunometabolism-based therapies to treat chronic autoimmune and inflammatory diseases through oral small molecules that modulate immune cell ...

Japanese drugmaker Eisai today announced the latest findings on etalanetug (development code: E2814) showed that this ...

US RNA medicines focused biotech Stoke Therapeutics today announced that Thomas McCauley has been appointed chief scientific ...

Medicines regulators in several major markets have issued a mix of approvals, safety communications, supply notices, ...

Elevar Therapeutics, a majority-owned subsidiary of South Korea's HLB (Kosdaq: 028300), has received a complete response ...